Tandem Mobi is the world’s smallest, durable automated insulin delivery system.1
Impressively small and offering next-level convenience and discretion, Tandem Mobi is controllable with a compatible, personal Android smartphone.*
Use of the Tandem Mobi mobile app requires a prescription. Always consult a healthcare professional for information about how to manage diabetes.
Features
Mobile Control via Android: Control the Tandem Mobi system directly from a compatible Android smartphone,* offering discreet and convenient access to therapy data and pump functions.
Advanced Therapy Visualization: View a 24-hour graphical representation of glucose readings (CGM and BGM), basal and bolus events, insulin on board, carbohydrate intake, suspensions, and other therapy-related data — all optimized for Android display.
Pump Status Monitoring: Real-time visibility into pump battery level, available insulin, active Personal Profile, CGM sensor and transmitter status, and more.
Customizable User Experience: Personal Profiles and activity settings allow users to tailor therapy to their lifestyle with enhanced personalization features available through the Tandem Mobi mobile app.
Powered by Control-IQ+ technology: Only Tandem systems are powered by Control-IQ+ with AutoBolus.† Turn it on and see improvements on Day 1.2
AutoBolus: The only system with AutoBolus to help with missed meal boluses and preventing hyperglycemia.†
Seamless Data Sync: Wireless data uploads to the web-based Tandem Source platform ensures therapy data is securely backed up and accessible.‡
Alerts on the App: Receive pump alerts, alarms, and reminders directly on your Android smartphone, minimizing interruptions and maximizing discretion.
Alerts on the Pump: Alerts automatically display on your Tandem Mobi mobile app and signal you with a beep or vibration on the Tandem Mobi insulin pump, ensuring you’re promptly notified about pump safety conditions that need your attention.
*The mobile app requires a compatible smartphone model and operating system (sold separately). Only available to pump users who reside in the United States.
†If glucose values are predicted to be above 180 mg/dL, Control-IQ+ technology calculates an AutoBolus using the Personal Profile settings and a target of 110 mg/dL and delivers 60% of that value.
‡Uploads to the Tandem Source platform do not take place in real time and should not be relied upon by healthcare providers, pump users, or caregivers for remote patient monitoring. Standard carrier data rates may apply. Smartphone sold separately.
1As of Nov., 2025. Data on file, Tandem Diabetes Care.
2Beck RW, et al. Diabetes Technol Ther. 2023;25(5):329-342.